These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6121499)

  • 1. [Influence of piracetam on the aggregation of platelets (author's transl)].
    Vömel T; Platt D; Summa JD
    Aktuelle Gerontol; 1982 Jan; 12(1):12-4. PubMed ID: 6121499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Normalization of hyperreactive thrombocytes in patients with TIA by piracetam?].
    Grotemeyer KH; Hofferberth B; Hirschberg M
    Nervenarzt; 1986 Mar; 57(3):180-3. PubMed ID: 3960236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of piracetam (nootropil) in the rehabilitative treatment of the middle-aged and elderly who have had a stroke].
    Man'kovskiĭ NB; Kostiuchenko VG; Tereshchenko LA; Tordiia GD
    Vrach Delo; 1980 Sep; (9):73-7. PubMed ID: 7423958
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of piracetam on cerebral hemodynamics in patients with arteriosclerosis and dyscirculatory encephalopathy].
    Vesel'skiĭ ISh; Voroniuk MI
    Klin Med (Mosk); 1986 Jun; 64(6):41-4. PubMed ID: 3747435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of neuroleptic side-effects with piracetam (author's transl)].
    Sikora J; Kabes J; Pisvejc J
    Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)].
    Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H
    Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the dose-effect relationship in the therapy with piracetam (author's transl)].
    Kretschmar JH; Kretschmar CH
    Arzneimittelforschung; 1976; 26(6):1158-9. PubMed ID: 786310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of Piracetam on the mental functional capacity of chronic alcoholics (author's transl)].
    Binder S; Doddabela P
    Med Klin; 1976 Apr; 71(17):711-6. PubMed ID: 775275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible uses of nootrophic drugs in clinical psychiatry (author's transl)].
    Molcan J; Vinar O; Pribyl R; Kolibás E; Caplová T; Heretík A
    Cesk Psychiatr; 1978 Apr; 74(2):52-60. PubMed ID: 357022
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
    Amroian EA; Vartazarian ND; Parsamian LK; Balian LS
    Biull Eksp Biol Med; 1990 Aug; 110(8):124-7. PubMed ID: 2127234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of GABA and piracetam on cerebral circulation and the neurogenic mechanisms of its regulation].
    Ivashev MN; Petrov VI; Shcherbakova TN
    Farmakol Toksikol; 1984; 47(6):40-3. PubMed ID: 6519254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various therapeutic effects of piracetam (1st part)].
    Houillon P; Kitenge A; Jouannigot R; Lullien L; Cadic F
    Ann Med Psychol (Paris); 1979 Sep; 137(6-7):605-10. PubMed ID: 507608
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Course of alcoholic predelirium during treatment with piracetam: results of serial psychometric tests (author's transl)].
    Meyer JG; Forst R; Meyer-Wahl L
    Dtsch Med Wochenschr; 1979 Jun; 104(25):911-4. PubMed ID: 446321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.
    Oepen G; Eisele K; Thoden U; Birg W
    Pharmacopsychiatry; 1985 Nov; 18(6):343-6. PubMed ID: 4089014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model.
    Stockmans F; Deberdt W; Nyström A; Nyström E; Stassen JM; Vermylen J; Deckmyn H
    Thromb Haemost; 1998 Jan; 79(1):222-7. PubMed ID: 9459351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nafamostat mesilate on ADP-induced platelet aggregation and disaggregation in hemodialysis patients.
    Miyata M; Shirakawa T; Acharya B; Terao S; Gotoh A
    ASAIO J; 2006; 52(3):272-5. PubMed ID: 16760715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.